Bellevue Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.3K Hold
55
﹤0.01% 366
2026
Q1
$4.76K Hold
55
﹤0.01% 324
2025
Q4
$5.28K Hold
55
﹤0.01% 340
2025
Q3
$5.24K Hold
55
﹤0.01% 341
2025
Q2
$4.79K Hold
55
﹤0.01% 344
2025
Q1
$4.94K Hold
55
﹤0.01% 327
2024
Q4
$4.39K Buy
+55
New +$4.76K ﹤0.01% 363
2021
Q2
Sell
-44
Closed -$5K 628
2021
Q1
$5K Hold
44
﹤0.01% 430
2020
Q4
$5K Hold
44
﹤0.01% 428
2020
Q3
$5K Hold
44
﹤0.01% 393
2020
Q2
$4K Hold
44
﹤0.01% 428
2020
Q1
$4K Buy
+44
New +$4.68K ﹤0.01% 418

Other funds holding MDT

Bellevue Asset Management's MDT Position: Q2 2026 in Review

Bellevue Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 55 shares worth $4.3K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Bellevue Asset Management first reported a position in MDT in Q1 2020 and has held it in 12 quarters since. The position peaked at $5.28K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bellevue Asset Management held 55 shares of Medtronic worth $4.3K as of Q2 2026.
  • Bellevue Asset Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #366 holding.
  • Bellevue Asset Management first reported a position in Medtronic in Q1 2020 and has held it in 12 quarters since.
  • Bellevue Asset Management's Medtronic position peaked at $5.28K in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.